Popular Articles

MAP Pharmaceuticals Phase 3 Trial Of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that the efficacy portion of its first Phase 3 clinical trial evaluating its novel LEVADEX(TM) orally inhaled migraine therapy met all four primary endpoints. Additional endpoints showed that LEVADEX provided rapid and sustained pain relief for up to 48 hours after dosing.
generic viagra online
More Effective Tools For Detection Of Colorectal Cancer Identified By New Research
The latest advances in polyp detection, assessment of colorectal cancer risk, and patient sedation during colonoscopy will be presented today at Digestive Disease Week® 2009 (DDW®). Research regarding the size and type of polyps detected during colonoscopy and the risk associated with developing colon cancer offers new insight into the recommended frequency of follow-up preventive colonoscopy. New research also examines the risk of perforation during colonoscopy and new tools allowing physicians to more closely examine polyps during colonoscopy including optical biopsy and deep sedation of the patient will be presented. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
News of the day
Medical Defence Union's New Scottish Recruits Help Meet Doctors' Demands For Medico-Legal Advice, UK
The Medical Defence Union (MDU) has recruited three new medico-legal advisers in Scotland, bringing its team of experts north of the border to nine - its biggest ever team in the country.
Cardiovascular

Washington D.C., Officials Urge Lawmakers To Block House Amendment That Would Impact Local Needle Exchange Programs

This week Del. Eleanor Holmes Norton (D-D.C.) and other Washington, D.C., officials "were racing to persuade congressional leaders to erase a House amendment that would essentially reinstate" a ban on using the district"s tax dollars to fund needle exchange programs, the Washington Post reports. A House bill including an amendment addressing needle exchange approved last week, which gives the district its federal appropriation for fiscal year 2010, "would prohibit the city from providing money to any needle exchange program that operates within 1,000 feet of virtually any location where children gather," according to the Post. Norton said, "It essentially wipes out the program," adding that she is calling on other lawmakers to pay close attention to any similar language in the Senate"s version of the bill, which is still in committee. According to the Post, "If the Senate does not include a similar amendment in its version of the bill, members would iron out their differences in a conference committee after Congress returns from its August recess. That"s where [district] officials and AIDS activists hope to kill the amendment" (Fears, 7/31). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):